|
1
|
- Gwen V. Childs, Ph.D.
- childsgwenv@uams.edu
- http://cytochemistry.net/cell-biology/medical/
|
|
2
|
- You are a cardiologist, asked to consult on the case of Mr. James
Murphy, a 35 yo man who just had a heart attack.
- As you take his history, he is normal weight, but his cholesterol is 440
mg/dl.
- His father died of a heart condition at age 50. He had been adopted, so
Mr. Murphy did not know his family history.
- You learn that his older sister, Jane, also had a heart attack (at age
45) but is recovering and being treated for high cholesterol. His
younger bother also has high cholesterol (500 mg/dl).
- Two other younger siblings appear OK.
- Is this family history unusual?
|
|
3
|
- You are concerned by the number of family members with cardiac problems
and decide to test everyone.
- When cholesterol tests came back, your suspicions are confirmed:
- Mrs. Joan Murphy, age 35, 160 mg/dl
- Mary Murphy, age 10, 140 mg/dl
- James Murphy Jr, age 6, 500 mg/dl
- Brian Murphy, age 4, 150 mg/dl
- John Murphy, age 2.5, 350 mg/dl
- Are these values unusual?
- To solve this case, you will need to know about receptor mediated
endocytosis!
|
|
4
|
|
|
5
|
- Toxins
- Antibodies
- Viruses
- Hormones
- Growth factors
- Serum Transport proteins
- LDL (What is this protein?)
|
|
6
|
|
|
7
|
|
|
8
|
- Receptor: membrane-spanning protein with binding sites for ligand in
extracellular domain.
- Ligand binding: causes rapid activation of second messengers in a
cascade that eventually affects cell (stimulates, inhibits, etc.).
- One does not always need receptor mediated endocytosis to activate or
inhibit a cell. Often, just the
binding to the extracellular domain will activate the receptor mediated
cascade.
|
|
9
|
- Concentration allows regulated entry of fluids.
- If there wasn’t some organization, there would be too much fluid
entering.
- This makes more work for the cell.
|
|
10
|
|
|
11
|
|
|
12
|
|
|
13
|
|
|
14
|
|
|
15
|
|
|
16
|
- Transfected cells with gene for clathrin linked to green fluorescent
protein.
- Followed route of clathrin and its mobility in the membrane. Green fluorescent protein became the
signal for clathrin.
- Looked at mobility and formation of coated pits.
|
|
17
|
- Time lapse photography suggests that coated pits appear, then disappear:
constantly being reformed.
- When the early and later images were superimposed, the coated pits
tended to reappear in the same place, as if they were anchored or
somehow “organized”.
- It is believed that they are held in place by cytoskeletal system.
|
|
18
|
|
|
19
|
- Receptors are transmembrane proteins that may span the membrane.
- Proteins called “β Arrestins” assist in the guiding of the
receptors to the clathrin-coated pits.
- Receptors have a signal sequence at the end of their cytoplasmic domain
(carboxy terminus): Tyrosine-X- Arginine-Phenylalanine
- Signal sequence binds to adaptin molecules in the clathrin coat. (Adaptor
protein AP-2). β Arrestins also facilitate this binding.
- This stops and concentrates the receptor. It stays inside the pit.
- Signal sequence even stimulates more clathrin to accumulate
|
|
20
|
- The pit invaginates and eventually is bound to the plasma membrane by a
narrow stem, sort of like an inverted goblet.
- Dynamin, a GTPase, becomes
associated with the stem-like connection to the plasma membrane.
- Hydrolysis of GTP provides the energy needed for constriction and loss
of this connection and ultimate formation of the clathrin-coated vesicle
carrying the receptor and ligand as cargo.
- The clathrin coated vesicle then loses its coat and then fuses, by a
specific sorting signal, with other vesicles to form the early endosome.
|
|
21
|
|
|
22
|
|
|
23
|
- There is a genetic defect in LDL receptors which prevents them from binding to
Adaptin-2 .
- Thus, they do not enter clathrin coated pits and cannot be brought into
the cell via receptor mediated endocytosis.
- The result is high serum cholesterol, because LDL provides a critical
mechanism for reducing cholesterol levels and getting it into the cells.
|
|
24
|
|
|
25
|
- Hypercholesterolemia. There is a
familial form that comes from a mutation in the LDL receptor. It binds
cholesterol, but never lets it enter the cells.
- Mr. Murphy and 2/4 of his children had this disease. Also, his father and 2/5 siblings had
it. What kind of inheritance?
- Will cause heart attacks (early) and atherosclerosis.
|
|
26
|
- To understand what happens to cholesterol, need to know about
trafficking through the endosomes.
- Vesicles lose clathrin coat and then fuse to form early endosome. (pH 5.9-6.0)
- In order to fuse, they carry a rab5 sorting signal linked to guanosine
diphosphate (GDP)
- Also have “v-snares and t-snares”
|
|
27
|
|
|
28
|
- Early endosome can release some receptors from their ligand. Low pH of 6
allows release.
- Receptors are then recycled back
to the plasma membrane (pH >6).
- Then, early endosome may become a late endosome.
|
|
29
|
|
|
30
|
|
|
31
|
|
|
32
|
- Within a few minutes of membrane recycling, the early endosome becomes a
late endosome.
- Characteristics:
- pH lowers further to 5.0-6.0
- Rab sorting signal changes to rab7-GDP
- Membrane rich
- Distinguished by Lysobisphosphatidic acid (LBPA) , a lipid
- Communicates with the Golgi complex
|
|
33
|
- Vesicles from trans Golgi C.: deliver acid hydrolases
- Recall that acid hydrolases are sorted in Golgi complex, bound to
mannose 6 phosphate receptors (M6PR).
- What type of body is forming at this point?
|
|
34
|
- Degradation
- many proteins, lipids, receptors that are not recycled.
- Releases free cholesterol
- Recycles to Golgi complex
- Receptors that are not degraded
- Mannose 6 phosphate receptor back to Trans Golgi network.
- Eventually fuses with lysosomes.
|
|
35
|
- pH continues to fall to 4-5
- Heavy degradation
- End point of endocytic pathway
- receptors that are not recycled are degraded, along with the ligand
- LAMP1 positive bodies.
- Not Mannose 6-Phosphate Receptor positive
|
|
36
|
|
|
37
|
- They regulate trafficking of critical nutrients.
- They also regulate cellular stores of different molecules, by
enzymatically degrading them.
- If there is a failure in the trafficking or degradation, the lysosome
will build up the product and eventually this will damage the cells.
- There may be rather wide-spread effects throughout the body.
|
|
38
|
- Types A and B involve a deficiency in acid sphingomyelinase—(ASM)
- Lack of ASM in lysosome will cause a lipid buildup.
- Seen prominently in macrophages (cells that have a lot of lysosomes).
- Lipid buildup eventually kills cells and damages organs, like spleen
and liver.
- Type A is associated with neurological tissues and usually causes death
within 2-3 years.
- Type B symptoms: enlarged spleen, respiratory problems, cardiovascular
problems, can live into adulthood.
- Autosomal recessive
|
|
39
|
|
|
40
|
- In the NPC disorder, there is a mutation in the NPC1 protein, which is
needed for cholesterol transport.
- Cholesterol accumulates in late endosomes which also appear expanded. It
is “stuck in traffic” and can’t get out of the endosomes.
- This also blocks retrograde transport of mannose 6 phosphate receptors
to the Golgi complex.
|
|
41
|
|
|
42
|
- Type C Niemann-Pick usually affects children of school age, but the
disease may strike at any time from early infancy to adulthood. Always
fatal.
- Some of the symptoms may include:
- Jaundice at (or shortly after) birth;
An enlarged spleen and/or liver
- Difficulty with upward and downward eye movements (Vertical
Supranuclear Gaze Palsy).
- Slurred, irregular speech ("dysarthria")
- Learning difficulties and progressive intellectual decline
("dementia")
- Sudden loss of muscle tone which may lead to falls
("cataplexy")
|
|
43
|
- Receptor must have recognition sites for ligand. Binding may activate
second messengers.
- Receptor must also have recognition site for clathrin coated pit (for
adaptin)
- Clinical significance--hypercholesterolemia
- Endocytic vesicles must have specific rab5-GTP’s to fuse and form early
endosome.
- Early endosome will recycle some receptors,
|
|
44
|
- Late endosome must have rab7 GDP recognition sites for fusion and
communication with the Trans Golgi network.
- Site for release of cholesterol—Clinically significant for Nieman Pick
C
- Site for recycling of Mannose 6 phosphate receptors.
- Lysosomes are the final stop in the endocytic pathway.
- Site for degradation of membranes, proteins, and lipids—Clinically
significant for Neiman Pick A and B
|